eeds - Enduring Material

Continue to Enduring Material

7600 Central Avenue
Philadelphia, PA 19111

General Information

Active Dates

Monday, February 7, 2022 - Saturday, December 31, 2022

Conference Host

Fox Chase Cancer Center

Conference Location

Virtual Conference Room

Conference Name

20th Annual Highlights of the 2021 San Antonio Breast Cancer Symposium

Provider

Temple Health

Other Comments

References - available in the presentation slides.

Objectives

Series Objectives

Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.

Presentations and Speakers

Presentation #1

HER 2 + Breast Cancer

Lori J Goldstein, MD

Available Credits/Points

Credit Designation

Temple Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

Disclosure Statements

Series Disclosures

Lori J Goldstein, MD, Program Director, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Daiichi Sankyo - DSMB - Relationship Has Not Ended
• Genentech - Advisory Committee Member - Relationship Ended
• Eisai - Advisory Committee Member - Relationship Has Not Ended
• Astra Zeneca - Advisory Committee Member - Relationship Ended
• Merck - Advisory Committee Member - Relationship Has Not Ended
• Exact Sciences - Advisory Committee Member - Relationship Ended
• Immunomedics - Advisory Committee Member - Relationship Ended
• Biovica Divitum - Advisory Committee Member - Relationship Ended

All relevant financial relationships with ineligible companies have been mitigated.

Event Disclosures

Planners and other Administrative Support:

Lori J Goldstein, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

Daiichi Sankyo - DSMB - Relationship Has Not Ended
Genentech - Advisory Committee Member - Relationship Ended
Eisai - Advisory Committee Member - Relationship Has Not Ended
Astra Zenica - Advisory Committee Member - Relationship Ended
MERCK - Advisory Committee Member - Relationship Has Not Ended
Exact Sciences - Advisory Committee Member - Relationship Ended
Immunomedics - Advisory Committee Member - Relationship Ended
Biovica Divitum - Advisory Committee Member - Relationship Ended

All of the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement

Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Test Information

Percentage of Correct Responses Required to Pass

80 %

Percentage of Responses Required to Submit

100 %

Last Review Date

2/7/2022

Continue to Enduring Material